Recon: Pfizer to pay $93M to resolve Lipitor antirust complaint; FTC to examine group purchasing organizations
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States